Headache is often reported among patients following a hemorrhagic stroke.

In a systematic review and meta-analysis, Bradley Ashley Ong, MD, a neurologist at the Cleveland Clinic in Ohio, and colleagues set out to assess headache frequency among patients after a hemorrhagic stroke. These findings were presented at the 2026 American Headache Society annual meeting.

The research team included 22 primary research articles in the meta-regression and meta-analysis, and 43 in the systematic review. The studies were published between inception and 2024.  The researchers searched the CENTRAL, MEDLINE, and PubMed databases for clinical trials and observational studies investigating headaches following a hemorrhagic stroke.

The meta-analysis included studies that reported frequency data and primarily included adult study populations, while the systematic review highlighted studies that explored headaches following hemorrhagic stroke.

The results indicated that the overall pooled headache frequency after hemorrhagic stroke was 46%. Specifically, prevalence was 38% (95% CI: 25–53%) among patients with intracerebral hemorrhage and 48% (95% CI: 37–59%) among those with subarachnoid hemorrhage.

Considering the human development index, population source, risk for bias, and geographic region, the meta-regression did not find statistically significant differences.

Other data showed that being female was associated with higher odds of experiencing headaches after hemorrhagic stroke (pooled OR 0.82, 95% CI 0.68–0.99; n = 7 studies), indicating female sex as a risk factor.

Conversely, patients with a prior medical history of primary headache had greater odds of experiencing headaches after hemorrhagic stroke (pooled OR 4.83, 95% CI 2.10–11.10; n = 7 studies), establishing previous primary headache as a significant risk factor.

“Future research should use standardized diagnostic criteria, clearly define study populations, and report detailed headache characteristics. There is also a lack of clinical trials on post-stroke headache treatments, highlighting the need for studies on effective preventive therapies and secondary prevention strategies. Further research is essential to better understand the nature of these headaches, which will help shape treatment protocols and enhance patient care,” the researchers concluded.